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Estrogen stimulates the neurite outgrowth response of medial basal hypothalamic neurons maintained in culture. We show here that one effect of estrogen is to promote an increase in 7, but not in tubulin, microtubule-associated protein la (MAP-la), or MAP-2 protein levels. This response precedes and accompanies an increase in stable microtubules and in neurite length. Taken collectively, our data suggest that estrogen-enhanced neurite growth is mediated by a selective induction of microtubule-stabilizing factors, namely, the T proteins.
During recent years, the importance of gonadal steroids hormones for the growth and differentiation of neurons and their neurites has become increasingly evident. Thus, several in vitro studies have shown that sex steroids are capable of promoting neuronal survival or neurite extension and arborization in explants or dissociated cell cultures from different brain areas (Faivre-Bauman et al., 198 1; Loudes et al., 1983; Reisert et al., 1987; Toran-Allerand, 1976a ,b, 198 1, 1983 , 1985 , Toran-Allerand et al., 1988 Uchibori and Kawashima, 1985a,b) . There is considerable interest in determining the mechanisms underlying these growth-promoting effects of steroids because they may provide some clue for understanding how the sexual dimorphic organization of the brain is brought about (ToranAllerand, 1981 (ToranAllerand, , 1985 .
Unfortunately, little is known about how these hormones exert their neuritogenic effect or about the elements of the neuron involved in this response. Because microtubule assembly is one of the key events involved in neurite elongation (Mitchison and Kirschner, 1988) , it may well be that sex steroids exert their action by modifying and/or enhancing the expression of microtubule-associated proteins (MAPS; Matus, 1988) which are known to promote tubulin polymerization or microtubule stability during active process extension (Greene et al., 1983; Drubin et al., 1985 Drubin et al., , 1988 Black et al., 1986; Brugg and Matus, 1988; Tucker et al., 1988; Ferreira et al., 1989 Ferreira et al., , 1990 . With these considerations in mind, we have chosen to analyze the effect of estrogen upon the growth of neurites and the pattern of expression of several microtubular proteins in dissociated cultures of hypothalamic neurons. thalamus, which extended from the caudal edge of the optic chiasm to the rostra1 edge of the mammilary body, laterally to the hypothalamic sulci and about as deep as 0.5 mm. These pieces oftissue were incubated in a solution containing 0.25% trypsin for 30 min at 3l"C, and then they were washed and passed through a constricted Pasteur pipette. The resulting cell suspension was plated onto poly-D-lysine-coated glass coverslips at densities ranging from 5000 to 15,000 cells per cm2. The tissue culture medium employed was Eagle's minimum essential medium supplemented with either 10% fetal calf serum or the N2 mixture of Bottenstein and Sato (1979) . Once every 3 d, l/z of the culture medium was replaced with fresh medium. In all cultures maintained with serumsupplemented medium, cytosine arabinoside (50 PM) was added to the culture medium to avoid the growth ofnon-neuronal cells. In this regard, it is worth mentioning that double immunofluorescence labeling of hypothalamic cell cultures with neuron-specific (MAP-2 or class III p-tubulin) or glial-specific [glial fibrillary acidic protein (GFAP)] antibodies revealed that more than 95% of the cells were MAP-2 positive (+; or class III &tubulin+) and GFAP negative (-), while about 3% were MAP-2/GFAP+.
Treatment of the cultures with steroid hormones (see below) did not alter the proportion of neuronal versus non-neuronal cells, at least during the first week in culture, the time period used in the present study.
Experimental cultures were treated with estradiol 17-p, estradiol 17-01, or estrone (final concentration in the culture medium was 0.1 PM). The steroids were dissolved in ethanol at a concentration of 100 &50 pl; 5 pl of this solution was then added to 100 ml of tissue culture medium; control, nontreated cultures received an equal amount of ethanol. For some experiments, culture medium was replaced with fresh medium containing 10 PM colchicine; cells were then maintained in this medium for 3 or 6 hr. The microtubules remaining in the Triton X-lOO-insoluble fraction from cultures treated with this depolymerizing agent are referred to as colchicine-resistant microtubules (see also Ferreira et al., 1989 Ferreira et al., , 1990 .
Microtubule protein level determination, morphometric analysis, and immunocytochemistry. Cytosolic or detergent-extracted cytoskeletal fractions from cell cultures were prepared as described by Ferreira et al. (1989) , and the levels of several microtubular proteins (tubulin, acetylated cy-tubulin, MAP-la, MAP-2, and 7) were determined by dot immunobinding (Caceres et al., 1988) with monoclonal antibodies that have been extensively characterized.
They included the following:
tubulin antibodies against all isoforms of a-tubulin (clone DM 1 A, Blose et al., 1984) or fi-tubulin (clone Tu9B; Caceres et al., 1984) , the clone Tu-Jl against the Class III neuron-soecific B-tubulin isoform (Moodv et al., 1589) , and the clone 6-l 1Bl against the acetylated isoform df cu-tubulin (Pipemo et al., 1987) ; (2) MAP-2 antibodies against different nonphosphorylated epitopes of this molecule (clones AP-9 and AP-14; Caceres et al., 1984) : and (3) 7 monoclonal antibodies against nonphosphorylated epitopes of 'these molecules (clones Tall-I-and 5 E2; Binder et al.. 1985 : Kosik and Finch. 1987 : Dotti et al.. 1987 : Ferreira I I et al., 1989 ,' 1990 Caceres and Ko$ik, 1990) . Standard curves were constructed, and the amount of each of the proteins analyzed in unknown samples was determined by extrapolation of the linear regions of the unknown to the linear portions of the standard. Also, the relative amount of the microtubular proteins was determined by scanning antibody-stained Western blots of cytosolic fractions as described previously (Ferreira et al., 1989) . Mean total axonal and dendritic length of individual neurons was quantified on camera lucida drawings using an Apple digitizer (Apple Computer Inc.). A total of 50 cells was measured for each time point of an experimental condition; statistical comparisons were made using appropriate 2-way analysis of variance (ANOVA). Immunocytochemistry of cell cultures was performed as previously described (Caceres et al., 1986; Ferreira et al., 1987 Ferreira et al., , 1989 .
Results
Neuroblasts of the E 17 medial basal hypothalamus maintained in culture display a sequence of morphological changes that result in the establishment of differentiated axonal and dendritic domains. Within a day after plating, these cells display short and thin neurites (3-5 per cell), which taper with distance. A similar morphology is observed after 3 d in vitro (DIV), with the exception that one of the neurites is several times longer than the others (Fig. 1) ; the morphological characteristics of this type of neurite resemble those described for axonal processes in both hippocampal (Barlett and Banker, 1984; Caceres et al., 1986; Dotti et al., 1987) and cerebellar cell cultures (Ferreira and Caceres, 1989; Ferreira et al., 1989) . The remaining neurites acquire morphological characteristics of dendrites; thus, they usually branch in Y angles, taper with distance, and grow at a much slower rate than the axons (Table 1) . Besides, dendrites, as opposed to axons, remain immunoreactive for MAP-2 throughout the course of neuronal development in vitro (data not shown; see also Ferreira et al., 1987) . A similar morphogenetic pattern is observed in neuroblasts obtained from the El9 hypothalamus; the main difference is that these neurons grow at a faster rate than El7 neurons ( Table 1 ).
The addition of estradiol 17-p to the culture medium results in a significant increase in axonal and dendritic length with respect to that observed in control, nontreated cells (Table 1) . On the other hand, no such effect is observed after the administration of estradiol 17-a (Table 1) or estrone (data not shown). In estradiol 17-P-treated hypothalamic neurons, the increase in neurite length becomes evident after 3 DIV for cultures prepared from the El 9 hypothalamus or 5 DIV in the case of E 17 ones; it occurs independent of the tissue culture medium employed. Our results also show that this phenomenon is not only the consequence of an increase in the linear length of a given neurite, but also reflects an increase in the number of neurite branches per cell (Table 2) ; however, it should be noted that the number of primary neurites that hypothalamic neurons extend is not modified by the administration of this hormone.
In control cells, polymeric tubulin, as determined with monoclonal antibodies that recognize all isotypes (clones DMlA or Tu9B), increases significantly and in parallel with axonal and dendritic length; a 2-3-fold increase in total tubulin levels is also detected in these neurons (Table 3) . Acetylated or colchitine-resistant microtubules begin to increase after the cells have developed in vitro for 3 d; after that time, microtubule mass and stable microtubules increase in parallel (Table 3; (HMW-MAPS) is also observed during the in vitro development posed to the other MAPS that are initially lost after colchicine of hypothalamic neurons; the time course of these inductions treatment (Table 3) . is identical to that of the increase in polymeric tubulin and Estradiol 17-P-treated neurons exhibit a similar profile; howneurite length. 7 protein levels also increase but with a time ever, the addition of this steroid, but not estradiol 17-a or escourse similar to that of the induction of stable microtubules trone, to the culture medium results in a 3-fold increase in the (colchicine-resistant and/or acetylated microtubules); besides, T levels of 7 proteins over the ones observed in control cells (Table  binds preferentially CR, colchicine-resistant. n Tubulin, MAP-la, MAP-2, and 7 protein levels were determined by quantitative dot immunobinding using I251 protein A, as described in Materials and Methods. h Hypothalamic cultures were prepared from El 7 fetuses. c Each value represents the mean * SEM from measurements of 5 hypothalamic cultures grown on 16-mm Aclar coverslips. Values are expressed in micrograms per millligram of total cellular protein.
the enhanced 7 induction begins at 3 DIV, and further increases are detected at 5 and 7 DIV. By 5 DIV, the levels of colchicineresistant (Table 3 , Fig. 2 ) or acetylated microtubules (data not shown) of estradiol 17-P-treated hypothalamic neurons are significantly higher than in control ones; an increase in polymeric tubulin is also evident at 7 DIV. 7 protein levels and stable microtubules also increase above control levels in estrogentreated cells of El9 hypothalamic cultures; the time course of this increase occurs earlier than in El7 neurons. In order to obtain further evidence of the effect of estrogen upon T induction, Western blot analyses were performed in cytosolic extracts obtained from control and treated cultures of different ages. Hypothalamic neurons in vitro express a Tau-1 immunoreactive polypeptide at M, 58,000, which migrates in a similar position to that of Tb from adult rat brain cytosolic fractions or microtubules (see Fig. 3 ). Cultures treated with estradiol 17-p display a similar pattern of 7 polypeptides with the difference that the expressed 7 isoform increases significantly with respect to the levels detected in control, nontreated cells and/or cells treated with estradiol 17-a. Densitometric analysis of Western blots shows a 3-fold increase in T protein levels in estradiol 17-P-treated hypothalamic cultures with respect to the values observed in control cultures; this increase is similar to that determined by dot immunobinding assay.
An enhanced induction of 7 and stable microtubules, as well as an increase in neurite length, is also detected when the steroid Table 4 ). On the other hand, the levels of total tubulin, MAP-la, and MAP-2 do not increase above those observed in control cells after the addition of estradiol 17-p; this phenomenon was observed under all the experimental conditions in which the steroid was added to the culture medium. However, an increase in the amount of MAP-la or MAP-2 bound to the cytoskeleton was evident at 7 DIV (see Table 2 ). detection method employed (immunoperoxidase vs. immunofluorescence), or concentration of the primary antibody. On the other hand, the majority of the neurons present in estradiol 17-,&treated cultures displayed an increase in 7 and acetylated a-tubulin immunoreactivity when compared with the control, nontreated cultures (Fig. 4) .
Discussion
Finally, in order to determine if the enhanced 7 induction
The present study provides evidence that supports and extends observed in estradiol 17-P-treated cells was related with a prefprevious observations indicating that epigenetic factors have a erential survival of specific classes of neurons containing higher key role as regulators of the expression of MAPS in developing 7 levels than others, cell cultures were stained with 2 monoclonal neurons (Drubin et al., 1983 (Drubin et al., , 1985 (Drubin et al., , 1988 Ferreira et al., 1987, antibodies against T proteins (clones Tau-1 and 5B2; Caceres 1989 Caceres , 1990 . Prior to evaluating these results, an analysis of the and Kosik, 1990) . As expected, r immunoreactivity was depattern of expression of MAPS in control hypothalamic neurons tected in both the control and the estrogen-treated hypothalamic seems pertinent. In these cells, axonal and dendritic growth are neurons; however, no differences in the intensity of staining were preceded and accompanied by a significant induction of neuronobserved among the neurons present within each of these exspecific MAPS. The time course of their increase is similar to perimental groups. This phenomenon was observed indepenthat reported for other brain neurons maintained in vitro (Coudent of the type of fixation (methanol vs. aldehyde fixation), chic et al., 1986; Cambray-Deakin et al., 1987; Ferreira et al., Figure 4 . a, Light micrograph showing the pattern of immunostaining of medial basal hypothalamic neurons after development in vitro for 5 d as revealed by immunocytochemistry with the monoclonal antibody Tau-1 diluted 1:50. As previously reported for other neurons that develop in culture (Dotti et al., 1987; Ferreira et al., 1987) immunoreactivity is found in both axons and dendrites. ZI, Cells from a sister culture to that shown in a stained with Tau-1 diluted 1:500; note the faint staining of neuritic processes. c, Light micrograph of estrogen-treated hypothalamic neurons after development in vitro for 5 d. The cells were immunostained with Tau-1 diluted 1:500, note the dramatic increase in r immunoreactivity when compared with the pattern displayed by the cells shown in b. Scale bar, 50 pm. day 4 (100 rig/ml) n Cell cultures were prepared from El7 rat embryos. * Values are expressed in Mm. ' 7 protein levels, expressed in micrograms per milligram oftotal cellular protein, were determined by dot immunobinding. d Acetylated a-tubulin levels were determined by dot immunobinding as described by Pipemo et al. (1987) . The numbers are expressed in cpm per microgram. They represent the slopes of regression lines; the numbers in parentheses are the corresponding coefficients of determination.
1989). Thus, HMW-MAPS display a pattern of expression that is highly coincident with the increase in total polymeric tubulin, while r proteins display one coincident with that of stable microtubules. These observations are consistent with the idea that MAP-1 a and/or MAP-2 are important factors involved in promoting microtubule assembly, and that 7 proteins are important in determining stability (Drubin et al., 1983 (Drubin et al., , 1985 (Drubin et al., , 1988 Matus, 1988; Ferreira et al., 1989 Ferreira et al., , 1990 . Besides, and as in the case of cerebellar macroneurons that develop in culture or neuronal tumor cell lines, total tubulin levels only increase slightly, a phenomenon that supports the idea that tubulin itself is not a limiting factor for regulating the formation of microtubules during nerve process extension (Drubin et al., 1985; Black et al., 1986; Ferreira et al., 1989 ). It is likely, then, that any substance that enhances the expression of MAPS may, in turn, increase the ability of the neuron to produce more microtubules and, hence, to grow longer and/ or more stable neurites; the dramatic and selective induction of MAP-2 observed during ganglioside-enhanced neurite growth clearly illustrates such a proposal (Ferreira et al., 1990) . The present results suggest that at least some of the neuritogenic effect of estrogen is mediated by a similar mechanism. Thus, our observations show that when estrogen enhances neurite growth, this hormone selectively increases 7 protein levels and, afterwards, stable microtubules.
This response seems not to be related to an overall increase in the expression of microtubular proteins, because no effects were observed in total tubulin levels or in the magnitude and time course of the HMW-MAP inductions; nor is it the consequence of an increased rate of growth or stability of estrogentreated neurons, because the enhanced r induction precedes the increase in axonal and dendritic length that is observed with respect to control, nontreated cells. Our results also suggest that this effect is not related to an enhanced survival of some type of neuron normally expressing high 7 levels, because the immunocytochemical analysis revealed identical levels of immunoreactivity within each of the experimental cell groups analyzed; besides, the enhanced 7 induction is also detected when estrogen is added to well-differentiated hypothalamic cultures. Also, it is worth mentioning that this effect was observed under serum deprivation, where no glial cell proliferation occurs, ruling out the possibility that differential survival of neurons versus non-neuronal cells could have effects on levels of MAPS measured on a per protein basis.
The enhanced 7 induction in estradiol 17-P-treated cells is followed by an increase in stable microtubules; it is likely that both of these events are correlated, because 7 proteins are preferentially associated with them (Ferreira and Caceres, 1989; Ferreira et al., 1989 Ferreira et al., , 1990 , and previous observations have shown that these proteins are capable of stabilizing microtubules in vivo (Drubin and Kirschner, 1986) .
The question that now arises concerns the relationship between these inductions and the reported increase in neurite length. One possibility is that this phenomenon simply reflects the existence of more stable neurites that, in response to fixation and/ or other experimental conditions, retract less than control, nontreated ones.
However, the alternative and most likely explanation is that, as a consequence of the expression of more stable microtubules, hypothalamic neurons are able to extend longer neurites with increased stability or to stabilize neurite branches that otherwise would retract. The increase in microtubule mass that accompanies the enhanced induction of stable microtubules supports this idea. Besides, this view is consistent with recent studies showing that, during early neuronal development in vitro, the phase of rapid neuritic elongation is marked by the appearance of a subset of stable microtubules and T associated with them (Ferreira and Caceres, 1989; Ferreira et al., 1989) , and that axonal elongation and the expression of stable microtubules is selectively blocked by antisense oligonucleotides directed against the 7 mRNA (Caceres and Kosik, 1990) . It is also in accordance with the proposal made by Kirschner and Mitchison (1986) suggesting that the expression of stable microtubules is critical for generating and maintaining cell asymmetries and with observations showing that neurons exhibiting a rapid increase in stable microtubules also have an enhanced rate of neurite growth (Cambray-Deakin et al., 1987; Burgoyne and Cambray-Deakin, 1988 ). It will now be of interest to determine if sex-related differences exist in the quantity and quality of brain microtubules. In this regard, it is worth noting that both developmental and androgen-induced changes in mRNAs coding for specific brain proteins, including tubulinlike molecules, have been identified in the hypothalamic preoptic area ).
Finally, the fact that we detected an increase in r and acetylated oc-tubulin immunoreactivity in the majority of the neurons present in the culture poses intriguing questions about the cellular and molecular mechanisms involved in these inductions. The questions about cellular and molecular mechanisms primarily relate to further data regarding the levels of receptor-or nonreceptor-containing, estrogen-responsive neurons in the type of culture we have employed. In this regard, one may consider the possibility that all cells express estrogen receptors, and hence, they directly respond to the hormone; alternatively, it may well be that estrogen exerts its effect acting on a small population of receptor-containing cells, which, in turn, produces and releases growth-promoting factors capable of enhancing the neuritogenic response of the entire cell population (see Toran-Allerand et al., 1988 , for a further discussion ofthis issue). Future studies should distinguish between these and related possibilities. 
